RGS2 and Alzheimer disease: Both RGS2 and DLGAP1 exhibited, in addition, lower expression in published gene expression data set (GSE5281; ref. 28) of postmortem AD compared with control brain tissues, and RGS2 exhibited lower expression also in a whole blood data set (GSE63060; ref. 29) of AD and MCI patients compared with control (Figures 4c–i).